Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 17, Pages -Publisher
MDPI
DOI: 10.3390/ijms22179573
Keywords
radiotherapy; immunotherapy; radio-immunotherapy; metastasis; oligometastasis
Funding
- Ludwig Cancer Research Foundation
- Foglia Family Foundation
Ask authors/readers for more resources
Radiotherapy and immunotherapy are most effective in treating cancer in the setting of low-volume disease. Further investigation of radio-immunotherapy in metastatic patients should focus upon patients with oligometastatic disease.
Radiotherapy and immunotherapy are most effective as cancer therapies in the setting of low-volume disease. Although initial studies of radio-immunotherapy in patients with metastatic cancer have not confirmed the efficacy of this approach, the role of radio-immunotherapy in patients with limited metastatic burden is unclear. We propose that further investigation of radio-immunotherapy in metastatic patients should focus upon patients with oligometastatic disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available